75
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Naive T cells undergo metabolic reprogramming to support the increased energetic and biosynthetic demands of effector T cell function. However, how nutrient availability influences T cell metabolism and function remains poorly understood. Here we report plasticity in effector T cell metabolism in response to changing nutrient availability. Activated T cells were found to possess a glucose-sensitive metabolic checkpoint controlled by the energy sensor AMP-activated protein kinase (AMPK) that regulated mRNA translation and glutamine-dependent mitochondrial metabolism to maintain T cell bioenergetics and viability. T cells lacking AMPKα1 displayed reduced mitochondrial bioenergetics and cellular ATP in response to glucose limitation in vitro or pathogenic challenge in vivo. Finally, we demonstrated that AMPKα1 is essential for T helper 1 (Th1) and Th17 cell development and primary T cell responses to viral and bacterial infections in vivo. Our data highlight AMPK-dependent regulation of metabolic homeostasis as a key regulator of T cell-mediated adaptive immunity.

          Related collections

          Author and article information

          Journal
          Immunity
          Immunity
          Elsevier BV
          1097-4180
          1074-7613
          Jan 20 2015
          : 42
          : 1
          Affiliations
          [1 ] Goodman Cancer Research Centre, McGill University, Montreal, QC, H3G 1Y6, Canada; Department of Physiology, McGill University, Montreal, QC, H3G 1Y6, Canada.
          [2 ] Departments of Medicine, Microbiology & Immunology, and Pathology, McGill International TB Centre, McGill University Health Centre and Research Institute, Meakins-Christie Laboratories, Montreal, QC, H2X 2P2, Canada.
          [3 ] Goodman Cancer Research Centre, McGill University, Montreal, QC, H3G 1Y6, Canada.
          [4 ] Goodman Cancer Research Centre, McGill University, Montreal, QC, H3G 1Y6, Canada; Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada.
          [5 ] Department of Microbiology and Immunology, McGill University, Montreal, QC, H3A 2B4, Canada; McGill University Health Centre Research Institute, Montreal General Hospital, Montreal, QC, H3G 1A4, Canada.
          [6 ] Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
          [7 ] Inserm, U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France, 75014; CNRS, UMR 8104, Sorbonne Paris Cité, Paris, France, 75014; Université Paris Descartes, Sorbonne Paris Cité, Paris, France, 75014.
          [8 ] Goodman Cancer Research Centre, McGill University, Montreal, QC, H3G 1Y6, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC, H3A 2B4, Canada.
          [9 ] Goodman Cancer Research Centre, McGill University, Montreal, QC, H3G 1Y6, Canada; Department of Physiology, McGill University, Montreal, QC, H3G 1Y6, Canada. Electronic address: russell.jones@mcgill.ca.
          Article
          S1074-7613(14)00497-X
          10.1016/j.immuni.2014.12.030
          25607458
          f7089557-c9d7-4c6d-963f-78102e656419
          Copyright © 2015 Elsevier Inc. All rights reserved.
          History

          Comments

          Comment on this article